_zuma-3-a-study-of-kte-c19-in-adults-with-relapsed-refractory-acute-lymphoblastic-leukaemia.jpg "ZUMA-3: A study of KTE-C19 in adults with relapsed refractory acute lymphoblastic leukaemia from c19 study Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 4 min 26 sec
✓ Published: 03-Jun-2019
✓ Published: 03-Jun-2019
Description:
Dr Bijal Shah talks to ecancer at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about the end of phase I results from the ZUMA-3 study. nnHe emphasises that acute lymphoblastic leukaemia remains an unmet need as adult patients with primary refractory disease who relapse usually have poor outcomes.nnDr Shah explains the mode of action of KTE-C19, and notes its similarities to the CAR T cell therapy approved in B cell lymphoma. nnIn the 45 patients enrolled, Dr Shah states t
Dr Bijal Shah talks to ecancer at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about the end of phase I results from the ZUMA-3 study. nnHe emphasises that acute lymphoblastic leukaemia remains an unmet need as adult patients with primary refractory disease who relapse usually have poor outcomes.nnDr Shah explains the mode of action of KTE-C19, and notes its similarities to the CAR T cell therapy approved in B cell lymphoma. nnIn the 45 patients enrolled, Dr Shah states t
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_omnichannel-launch-excellence-medical-and-commercial-best-practices.webp "We discussed our perspectives on post-C19 launch excellence last year, and we all agreed that the New Normal will never be the same. Ruud Kooi (SVP Global Accounts) and Ben Harbour (Senior Consultant) discussed on how to optimize your omnichannel launch and discover solutions to some of the potential obstacles you might face.nnnKey topics included:nn- How to create an evidence-based roadmap for Medical and Commercial omnichannel launchat the international and local leveln- 5 tips to optimize y")
_new-covid-vaccine-study-links-jab-to-heart-and-brain-conditions-124-wion-world-dna.webp "WION")
⏲ 2 minutes 19 seconds 👁 148.7K
_growing-proportion-of-covid-deaths-occur-among-vaccinated-analysis.webp "Eyewitness News ABC7NY")
_encephalitis-after-covid-19-vaccine-administration-perspectives.webp "MedCram - Medical Lectures Explained CLEARLY")
_more-vax-more-infection-newly-peer-reviewed-study-shocks-covid-logic-rising-reacts.webp "The Hill")
⏲ 11 minutes 41 seconds 👁 53.3K
_c19-immunity-task-force-study.webp "The goals of this study are to build a better understanding about how widespread COVID-19 is in our most vulnerable and high-risk populations, and to study the level and duration of protection of currently approved COVID-19 vaccines.")
_study-reveals-astrazeneca-and-pfizer-vaccines-linked-to-rare-neurological-side-effects.webp "Arirang News")
⏲ 41 seconds 👁 758.3K
_omnichannel-launch-excellence-medical-and-commercial-best-practices.jpg)
_new-covid-vaccine-study-links-jab-to-heart-and-brain-conditions-124-wion-world-dna.jpg)
_growing-proportion-of-covid-deaths-occur-among-vaccinated-analysis.jpg)
_encephalitis-after-covid-19-vaccine-administration-perspectives.jpg)
_more-vax-more-infection-newly-peer-reviewed-study-shocks-covid-logic-rising-reacts.jpg)
_c19-immunity-task-force-study.jpg)
_study-reveals-astrazeneca-and-pfizer-vaccines-linked-to-rare-neurological-side-effects.jpg)
![[+]](/images/menu.gif){kind=small}